T Rowe Price Overseas Stock's upcoming portfolio management transition should be smooth, and its attractive approach isn't changing. But the incoming manager's resume isn't as strong as that of the outgoing manager, so the strategy's People rating is lowered to Average from Above Average, while its Process rating remains Above Average.
T. Rowe Price Overseas Stock I TROIX
- NAV / 1-Day Return 13.78 / +0.80 %
- Total Assets 23.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.670%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 500,000
- Status Open
- TTM Yield 2.08%
- Turnover 7%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis TROIX
Will TROIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Siemens AG | 2.39 | 580.0 Mil | Industrials |
Taiwan Semiconductor Manufacturing Co Ltd | 2.37 | 576.5 Mil | Technology |
Nestle SA | 2.36 | 573.8 Mil | Consumer Defensive |
Unilever PLC | 2.05 | 497.9 Mil | Consumer Defensive |
ASML Holding NV | 1.99 | 484.6 Mil | Technology |
AstraZeneca PLC ADR | 1.96 | 477.1 Mil | Healthcare |
Novo Nordisk AS Class B | 1.80 | 437.6 Mil | Healthcare |
Munchener Ruckversicherungs-Gesellschaft AG | 1.79 | 434.9 Mil | Financial Services |
Broadcom Inc | 1.60 | 388.6 Mil | Technology |
Novartis AG Registered Shares | 1.57 | 380.9 Mil | Healthcare |